Oxford Biodynamics (OBD) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Oct 2022 02:30 PM
RNS
Result of Open Offer
07 Oct 2022 12:00 PM
RNS
Proposed Placing and Open Offer
03 Oct 2022 07:00 AM
RNS
US Reimbursement Code for CiRT now available
15 Sep 2022 07:00 AM
RNS
ESMO data highlights unique benefit of EpiSwitch
06 Sep 2022 07:00 AM
RNS
CiRT highlighted at ESMO 2022 presentation
05 Jul 2022 07:00 AM
RNS
US reimbursement code for EpiSwitch® CiRT
01 Jul 2022 04:13 PM
RNS
Director/PDMR Shareholding
28 Jun 2022 07:00 AM
RNS
Half-year Report
21 Jun 2022 07:00 AM
RNS
EpiSwitch® CiRT now available in the UK
17 Jun 2022 07:00 AM
RNS
Notice of Interim Results Webinar
15 Jun 2022 07:00 AM
RNS
Notice of Results
14 Jun 2022 07:00 AM
RNS
OBD EpiSwitch® CiRT well received at ASCO 2022
20 May 2022 03:50 PM
RNS
Director/PDMR Shareholding
20 May 2022 07:00 AM
RNS
PDMR Dealing / Grant of Share Options
13 May 2022 03:57 PM
RNS
PDMR Dealing / Grant of Share Options
05 May 2022 07:00 AM
RNS
OBD to present CiRT clinical utility data at ASCO
28 Apr 2022 10:54 AM
RNS
Director/PDMR Shareholding
11 Apr 2022 12:00 PM
RNS
Holding(s) in Company
08 Apr 2022 10:40 AM
RNS
PDMR Dealing
07 Apr 2022 10:36 AM
RNS
PDMR Dealing
06 Apr 2022 04:14 PM
RNS
PDMR Dealing
06 Apr 2022 04:03 PM
RNS
PDMR Dealing
30 Mar 2022 02:09 PM
RNS
Results of Annual General Meeting
04 Mar 2022 09:42 AM
RNS
PDMR Dealing
03 Mar 2022 09:58 AM
RNS
PDMR Dealing
01 Mar 2022 04:16 PM
RNS
PUBLICATION OF 2021 ANNUAL REPORT
25 Feb 2022 07:00 AM
RNS
US launch of EpiSwitch® CiRT for oncology
15 Feb 2022 10:17 AM
RNS
PDMR Dealing
10 Feb 2022 11:52 AM
RNS
PDMR Dealing
08 Feb 2022 03:10 PM
RNS
Holding(s) in Company
07 Feb 2022 02:47 PM
RNS
PDMR Dealing
26 Jan 2022 09:50 AM
RNS
PDMR Dealing
25 Jan 2022 11:44 AM
RNS
PDMR Dealing
25 Jan 2022 07:00 AM
RNS
Final Results
19 Jan 2022 09:58 AM
RNS
Holding(s) in Company
14 Jan 2022 02:36 PM
RNS
Holding(s) in Company
14 Jan 2022 07:00 AM
RNS
Holding(s) in Company
13 Jan 2022 12:00 PM
RNS
Holding(s) in Company
11 Jan 2022 09:00 AM
RNS
Holding(s) in Company
10 Jan 2022 07:02 AM
RNS
Holding(s) in Company
04 Jan 2022 07:00 AM
RNS
Holding(s) in Company
29 Dec 2021 04:00 PM
RNS
Holding(s) in Company
24 Dec 2021 11:40 AM
RNS
PDMR Dealing
23 Dec 2021 07:00 AM
RNS
Notice of Results
17 Dec 2021 07:00 AM
RNS
OBD updates on EpiSwitch CST and CiRT tests
13 Dec 2021 02:23 PM
RNS
Holding(s) in Company
13 Dec 2021 10:12 AM
RNS
PDMR Dealing
01 Dec 2021 12:00 PM
RNS
PDMR Dealing
24 Nov 2021 03:02 PM
RNS
PDMR Dealing
22 Nov 2021 11:00 AM
RNS
PDMR Dealing

Oxford Biodynamics' international store for clinical smart tests and research kits based on pioneering EpiSwitch® 3D genomic technology.

OBD was spun out of Oxford University in 2007 to commercialize blood tests based on 3D Genomics research. OBD's tests are designed to help people make informed health decisions and reduce healthcare costs.

OBD share price launched at 162p in 2016.

UK 100

Latest directors dealings